Recherches "plusieurs pathologies" AcSé Pembrolizumab Secured Access to Pembrolizumab for Adult Patients With Selected Rare Cancer Types. Saint-Cloud CAROLE SOUSSAIN
Recherches "plusieurs pathologies" AcSé Vemurafenib Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations Saint-Cloud ETIENNE BRAIN
Recherches "plusieurs pathologies" SUMMIT- PUMA-NER-0502 An Open-label, Phase 2 Study of Neratinib in Patients With Solid Tumors With Somatic Human Epidermal Growth Factor Receptor (EGFR, HER2, HER3) Mutations or EGFR Gene Amplification. Saint-Cloud FRANCOIS-CLEMENT BIDARD
Sein métastatique HER2+ MCLA-128-CL02 Phase 2 Study of MCLA-128-based Combinations in Metastatic Breast Cancer (MBC): MCLA-128/Trastuzumab/Chemotherapy in HER2-positive MBC and MCLA-128/Endocrine Therapy in Estrogen Receptor Positive and Low HER2 Expression MBC Saint-Cloud FRANCOIS-CLEMENT BIDARD
Appareil Digestif IMMUNO-BIL (D48-1 PRODIGE 57) Durvalumab Plus Tremelimumab Combination Immunotherapy With or Without Weekly Paclitaxel in Patients With Advanced Biliary Tract Carcinoma (BTC) After Failure of Platinum-based Chemotherapy: a Randomized Non-comparative Two-arm Phase II Study Saint-Cloud
Hématologie Lymphome non Hodgkinien GATA A Phase II Trial Evaluating Combination of Atezolizumab, With Venetoclax and Obinutuzumab for Relapsed/Refractory Lymphomas Saint-Cloud CAROLE SOUSSAIN
Sarcomes SARCOME 13 Multicentre, Randomised, Phase 2 Trial of Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients (Metastatic Osteosarcoma at Diagnosis or Localised Disease With Poor Histological Response) Paris SOPHIE PIPERNO-NEUMANN
Sarcomes BFR ESS 01 Randomized Comparative Prospective Multicentre Phase II Trial Evaluating Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic LGESS Paris SOPHIE PIPERNO-NEUMANN, SOPHIE PIPERNO-NEUMANN
Sein Néoadjuvant FIGARO Feasibility and Accuracy of Lymph-node (LN) Restaging by Sentinel LN Procedure and Axillary LN Dissection in Ipsilateral Invasive Breast Cancer Relapse Saint-Cloud
Appareil Digestif PERSPECTIVE (MS202202-0002) A Phase II Single-Arm Study to Investigate Tepotinib Combined With Cetuximab in RAS/BRAF Wild-Type Left-Sided mCRC Patients Having Acquired Resistance to Anti-EGFR Antibody Targeting Therapy Due to MET Amplification (PERSPECTIVE) Saint-Cloud